TY - JOUR
T1 - Diagnostic performance of regional cerebral blood flow images derived from dynamic PIB scans in Alzheimer’s disease
AU - Peretti, D. bora E.
AU - Vállez García, David
AU - Reesink, Fransje E.
AU - Doorduin, Janine
AU - de Jong, Bauke M.
AU - de Deyn, Peter P.
AU - Dierckx, Rudi A. J. O.
AU - Boellaard, Ronald
PY - 2019/12/1
Y1 - 2019/12/1
N2 - Background: In clinical practice, visual assessment of glucose metabolism images is often used for the diagnosis of Alzheimer’s disease (AD) through 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) scans. However, visual assessment of the characteristic AD hypometabolic pattern relies on the expertise of the reader. Therefore, user-independent pipelines are preferred to evaluate the images and to classify the subjects. Moreover, glucose consumption is highly correlated with cerebral perfusion. Regional cerebral blood flow (rCBF) images can be derived from dynamic 11C-labelled Pittsburgh Compound B PET scans, which are also used for the assessment of the deposition of amyloid-β plaques on the brain, a fundamental characteristic of AD. The aim of this study was to explore whether these rCBF PIB images could be used for diagnostic purposes through the PMOD Alzheimer’s Discrimination Tool. Results: Both tracer relative cerebral flow (R1) and early PIB (ePIB) (20–130 s) uptake presented a good correlation when compared to FDG standardized uptake value ratio (SUVR), while ePIB (1–8 min) showed a worse correlation. All receiver operating characteristic curves exhibited a similar shape, with high area under the curve values, and no statistically significant differences were found between curves. However, R1 and ePIB (1–8 min) had the highest sensitivity, while FDG SUVR had the highest specificity. Conclusion: rCBF images were suggested to be a good surrogate for FDG scans for diagnostic purposes considering an adjusted threshold value.
AB - Background: In clinical practice, visual assessment of glucose metabolism images is often used for the diagnosis of Alzheimer’s disease (AD) through 2-[18F]-fluoro-2-deoxy-d-glucose (FDG) positron emission tomography (PET) scans. However, visual assessment of the characteristic AD hypometabolic pattern relies on the expertise of the reader. Therefore, user-independent pipelines are preferred to evaluate the images and to classify the subjects. Moreover, glucose consumption is highly correlated with cerebral perfusion. Regional cerebral blood flow (rCBF) images can be derived from dynamic 11C-labelled Pittsburgh Compound B PET scans, which are also used for the assessment of the deposition of amyloid-β plaques on the brain, a fundamental characteristic of AD. The aim of this study was to explore whether these rCBF PIB images could be used for diagnostic purposes through the PMOD Alzheimer’s Discrimination Tool. Results: Both tracer relative cerebral flow (R1) and early PIB (ePIB) (20–130 s) uptake presented a good correlation when compared to FDG standardized uptake value ratio (SUVR), while ePIB (1–8 min) showed a worse correlation. All receiver operating characteristic curves exhibited a similar shape, with high area under the curve values, and no statistically significant differences were found between curves. However, R1 and ePIB (1–8 min) had the highest sensitivity, while FDG SUVR had the highest specificity. Conclusion: rCBF images were suggested to be a good surrogate for FDG scans for diagnostic purposes considering an adjusted threshold value.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85068762788&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/31273465
U2 - https://doi.org/10.1186/s13550-019-0528-3
DO - https://doi.org/10.1186/s13550-019-0528-3
M3 - Article
C2 - 31273465
SN - 2191-219X
VL - 9
JO - EJNMMI Research
JF - EJNMMI Research
IS - 1
M1 - 59
ER -